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1. Introduction 
The two major endogenous opioid pentapeptides, 
methionine-enkephalin and leucine-enkephalin [ 1,2] 
rapidly react with acetaldehyde, under very mild con- 
ditions, to give an ‘acetaldehyde-enkephalin’ adduct, 
referred to as ‘acetaldehyde-enkephalin [Met’] and 
‘acetaldehyde-enkephalin [Leu”], respectively 231. 
These adducts are sufficiently stable that their chemi- 
cal structure and biological activities can be deter- 
mined. We have shown that ‘acetaldehyde-enkephalin’ 
adduct formation causes a pronounced loss of the 
opiate activity of both parent opioid pentapeptides 
[3,4]. Because of this loss of activity we considered 
it important to determine the chemical structure of 
the acetaldehyde adducts, and the influence that 
acetaldehyde adduct formation has on the solution 
conformation of the enkephalins. In this first report, 
an analysis of the 100 MHz proton nuclear magnetic 
resonance (‘H NMR) spectra of methionine-enke- 
phalin and its corresponding stable acetaldehyde adduct 
has established that the latter arises by formation of a 
2-methylimidazolidin-4-one ring structure in which 
the acetaldehyde moiety forms a molecular bridge 
between the o-amino group of the N-terminal tyrosine 
residue and the amide nitrogen of the Tyr(l)-Gly(2) 
peptide bond. This is outlined in scheme 1, and 
detailed in the following discussion. 
2. Materials and methods 
2.1. Synthesis of methionine-enkephalin and ‘acetal- 
dehyde-enkephalin IMet’] 
Methionine-enkephal~ was prepared by standard 
Iwc,ne-enkephoiin. R- -Giy-L-Phc-L-k-OH / \ 
Scheme I 
liquid-phase synthesis as in [.5]. ‘Acetaldehydeenke- 
phalin [Met]’ was prepared by incubating methionine- 
enkephalin with acetaldehyde in 0.05 M’phosphate 
buffer (KH2P04/Na2 HP04) (pH 7 .O> at room tem- 
perature, and purified by the procedure in [3]. Other 
acetaldehyde-peptide adducts and ‘acetone-enkephal~ 
[Met’]’ were synthesised by standard methods [3]. 
2.2. Spectroscopic measurements 
‘H NMR spectra of 100 MHz were recorded on a 
Varian XL-100 spectrometer equiped with a decoupler 
unit, and operated at 30°C. NMR parameters: 100 
scans; acquisition time, 4.0 s; 8 k data points. Inte- 
grated and 80 MHz ‘H NMR spectra were obtained 
using a Varian CFT-20 spectrometer. 
Chemical shifts (in 6 values) are reported in parts per 
million (ppm) downfIeld from external tetramethyl- 
silane .
3. Results and discussion 
Structure elucidation of the ‘acetaldehydeenke- 
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phalin’ adducts has been primarily achieved by the use 
of ‘H NMR spectroscopy. However, reliable interpre- 
tation of the data has necessitated not only an analysis 
of the adducts indicated in the rubric to this paper, 
but also an investigation of the ‘N NMR spectrum of 
several other ‘acetaldehyde-peptide’ adducts and, in 
particular, the acetaldehyde derivative of the tripep- 
tide 
L-Tyr-Gly-Gly-OH (detailed in [3]); 
this adduct has been used extensively in our 100 MHz 
‘H NMR investigations because it retains many of the 
essential structural features of the 2 opioid pentapep- 
tides, but produces a considerably simpler spectrum. 
Proton assignments and coupling constants have been 
detailed in [6-l 0] and will, therefore, not be repeated 
here; proton resonances pertaining to the present 
discussion are included in fig.l,2, A noteworthy 
feature of the spectrum of methionine-enkephalin is 
the low field signal at 8.6 ppm of the amide NH of 
the Tyr(‘)-Gly(2) peptide bond in which both its 
position and broadening may be attributed to the 
proximity of the (r-NH2 of the N-terminal tyrosine 
residue [10,12-151. Other important features include 
the (Y proton resonances of the constituent amino 
acids occurring at 3.8,4.2 and 4.5 ppm corresponding 
to GIY(~>~), Me@) and Phef4), respectively. The Q: 
proton of Tyr(l) . IS not comp’letely resolved from the 
aCH, resonances of Glyc2) and Gl~(~l at 100 MHz. 
The ‘H NMR spectrum of methionine-enkephalin By contrast, the ‘H NMR spectrum of ‘acetalde- 
acetate is presented in fig.1. The 100 MHz spectrum, hyde-enkephalin [Met’]‘, shown in fig.2, indicates 
as shown, compares very well with previously recorded several important differences to that observed for 
spectra at 270 [6], 300 [7,8] and 360 MHz [9,10] methionine-enkephali in fig.1. Most striking is the 
using solutions of methionine-enkephalin in deuteriated disappearance of the amide NH of GIyc2) and the 
dimethylsulphoxide (dB-DMSO). Chemical shift appearance of new proton resonances at -4.3 and 
assignnlents are in broad agreement and any reported -1 .l ppm. Integration confirmed the loss of one 
major discrepancies, such as the assignment of individ- amide NH proton, the appearance of one additional 
ual amide NH resonances, have been attributed to a proton at 4.3, and 3 protons at 1 .l ppm. Further- 
pH and concentration dependence on the conforma- more, ‘H NMR studies, at both 80 and 100 MHz, on 
tion of methionine-enkephalin in solution [ 1 l-l 31. the ‘acetaldehydetripeptide (Tyr-Gly-Gly-OH)” 
Af-H 
J 
1 I 1 
8 7 6 5 4 3 2 I 
PPm 
Fig.1. 100 MHz ‘H NMR spectrum of methionine-enkephalin (10 mg/ml) in deuteriated imeulylsuiphoxide (d,-DMSO) at 30°C. 
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Fig.2. 100 MHz ‘H NMR spectrum of ‘acetaldehyde-enkephalin-[MetJ’ (8mg/ml) in d,-DMSO at 30°C. 
alluded to earlier, and on ‘acetaldehydeenkephalin 
[Met’]’ at 80 MHz have shown that the methyl signal 
of the latter is a double doublet (1.15 and 1 .lO ppm, 
J = 6.0 Hz). A similar methyl splitting pattern was 
observed with the ‘acetaldehyde-tripeptide’ (1.20 and 
1.15 ppm,J = 5.8 Hz) and, in addition, the methine 
proton resonance at 4.4 ppm was shown to be an 
overlapping double quartet (J = 5.8 Hz). Selective 
proton decoupling of ‘acetaldehyde-enkephalin 
[Met’]’ gave results consistent with the same double 
quartet pattern (J = 6.0 Hz). The major spectroscopic 
differences observed in the ‘H NMR spectra of ‘ace- 
taldehyde-enkephalin [Met’]’ can, therefore be 
attributed to a -CH-CHa unit with a vicinal coupling 
constant of 6.0 Hz, and the full ‘H NMR data are 
consistent with a 2-methylimidazolidin-4-one ring 
structure. Furthermore, the chemical shift of the 
methine proton is typical for a C-2 proton of a C-5 
substituted imidazolidin4-one [ 161, and the observed 
splitting pattern is also consistent with the formation 
of a diastereoisomeric mixture of the (2R,LS) and 
(2,S,5S)-2-methylimidazolidin-4-one derivative of 
methionine-enkephalin (see scheme 1); a diastereoiso- 
merit mixture is expected, since in the absence of 
asymmetric induction ring closure is presumed to 
occur with equal facility to either the re or si face 
[ 171 of the initially formed Schiff base. 
One interesting feature in the spectrum of ‘ace- 
taldehyde-enkephalin [Met’]’ is the appearance of 
two ‘rogue’ peaks at 3.80 and 3.95 ppm. The same 
pattern is seen with the ‘acetaldehyde-tripeptide’ and 
must therefore arise from the N-terminal sequence, 
Tyr-Gly-Gly-OH. ‘Acetone-enkephalin-[Met5]’ 
does not display a comparable pattern, which suggests 
that the additional resonances observed with the 
‘acetaldehyde-peptides’ are a consequence of either 
the formation of a new chiral centre or an extra 
proton at C-2 of the 2-methylimidazolidin-4-one ring 
structure. The protons responsible for these additional 
signals may provide important information on the 
solution conformation of the two diastereoisomers 
of ‘acetaldehyde-enkephalin [Met5]’ and we are cur- 
rently investigating this aspect using 300 MHz ‘H 
NMR spectroscopy and derivatives of methionine- 
enkephalin in which Glyc2) and Glyc3) have been 
replaced, in turn, by a-deuteriated analogues. 
Thus, the ‘H NMR data firmly establish the struc- 
ture of ‘acetaldehyde-enkephalins’ as the 2-methyl- 
imidazolidin-4-one derivative of the parent penta- 
peptides, and that related peptides with similar 
N-terminal amino acid sequences undergo the same 
facile reaction with acetaldehyde [3]. In particular, 
309 
Volume 111, number 2 FEBS LETTERS March 1980 
we have shown that ~~ndorph~, one of the major 
opioid peptides of pituitary origin [ 18,191 similarly 
loses opiate activity when incubated with aqueous 
solutions of acetaldehyde 131, and presumably forms 
the corresponding ‘acetaldehyde-/.%endorphin’ adduct. 
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